82 results
Page 3 of 5
6-K
EX-99.1
rfng jxmw
6 Aug 19
Aurinia Pharmaceuticals Inc. 6-K
4:02pm
6-K
EX-99.2
b1iax7y8c6hdp
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
6-K
EX-99.1
vcl 67citvsc7kqqh18b
14 May 19
Current report (foreign)
4:04pm
6-K
EX-99.2
miawwbs st3ab8rx8
14 May 19
Current report (foreign)
4:04pm
6-K
EX-99.1
lgmh fwzm
10 May 19
Aurinia Pharmaceuticals Inc. 6-K
7:00am
40-F
EX-99.2
y00oamds jwdzevtgd3
19 Mar 19
Annual report (Canada)
4:16pm
40-F
EX-99.1
kd8vot cnidkhwwr
19 Mar 19
Annual report (Canada)
4:16pm
40-F
y40r8b696xu
19 Mar 19
Annual report (Canada)
4:16pm
40-F
EX-99.3
oubykozvs5 gr0c4yd
19 Mar 19
Annual report (Canada)
4:16pm
6-K
EX-99.1
yv4v6fk4fwr9adb5j
22 Jan 19
Aurinia Pharmaceuticals Inc. 6-K
7:00am
6-K
EX-99.2
fk6u1n6gr6k
30 Nov 18
Current report (foreign)
5:27pm
SUPPL
it7oe jqm2
30 Nov 18
Supplemental materials (foreign)
5:23pm
6-K
EX-99.1
78d8 g4snfcg90jrw0fc
11 Jul 18
Aurinia Initiates Phase 2 Clinical Trial for Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome
4:01pm
6-K/A
EX-99.3
ic1s 5avicl
17 May 18
Current report (foreign) (amended)
12:00am
6-K
EX-99.1
6edkuuhddy8kfsnqukj
20 Apr 17
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
2pj2 f37u
20 Apr 17
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
2fidvjyy
21 Nov 16
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
3adbjdvrtugc7nild8
24 Oct 16
Aurinia Announces Acceptance of Late-Breaking Voclosporin Abstracts for Oral Presentation at Upcoming Medical Meetings
12:00am
6-K
EX-99.1
7uvblk4x4qmoxauq5xt1
6 Oct 16
Aurinia Releases Open-Label AURION Data Demonstrating Increased Remission Rates over Time for Voclosporin in the Treatment of Lupus Nephritis
12:00am
F-10/A
06i9oer43x2y
16 Oct 15
Registration of securities (Canada) (amended)
12:00am